Role of stereotactic body radiotherapy for early-stage non-small-cell lung cancer in patients borderline for surgery due to impaired pulmonary function.
Natsuo TomitaKatsuhiro OkudaNozomi KitaMasanari NiwaShingo HashimotoTaro MuraiSatoshi IshikuraRyoichi NakanishiYuta ShibamotoPublished in: Asia-Pacific journal of clinical oncology (2022)
Our study suggests that SBRT is a reasonable option for patients with e-stage NSCLC and impaired PF who are considered borderline candidates for surgery.
Keyphrases
- early stage
- minimally invasive
- coronary artery bypass
- end stage renal disease
- radiation therapy
- ejection fraction
- newly diagnosed
- small cell lung cancer
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- surgical site infection
- squamous cell carcinoma
- advanced non small cell lung cancer
- sentinel lymph node
- locally advanced
- percutaneous coronary intervention
- patient reported
- rectal cancer